170 related articles for article (PubMed ID: 21922135)
1. Clinical significance of UNC5B expression in colorectal cancer.
Okazaki S; Ishikawa T; Iida S; Ishiguro M; Kobayashi H; Higuchi T; Enomoto M; Mogushi K; Mizushima H; Tanaka H; Uetake H; Sugihara K
Int J Oncol; 2012 Jan; 40(1):209-16. PubMed ID: 21922135
[TBL] [Abstract][Full Text] [Related]
2. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of osteoprotegerin expression in human colorectal cancer.
Tsukamoto S; Ishikawa T; Iida S; Ishiguro M; Mogushi K; Mizushima H; Uetake H; Tanaka H; Sugihara K
Clin Cancer Res; 2011 Apr; 17(8):2444-50. PubMed ID: 21270110
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion.
Lin BR; Huang MT; Chen ST; Jeng YM; Li YJ; Liang JT; Lee PH; Chang KJ; Chang CC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S385-94. PubMed ID: 21681381
[TBL] [Abstract][Full Text] [Related]
5. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide screening for methylation-silenced genes in colorectal cancer.
Khamas A; Ishikawa T; Mogushi K; Iida S; Ishiguro M; Tanaka H; Uetake H; Sugihara K
Int J Oncol; 2012 Aug; 41(2):490-6. PubMed ID: 22664866
[TBL] [Abstract][Full Text] [Related]
7. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
8. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
[TBL] [Abstract][Full Text] [Related]
9. Down-regulated GAS1 expression correlates with recurrence in stage II and III colorectal cancer.
Jiang Z; Xu Y; Cai S
Hum Pathol; 2011 Mar; 42(3):361-8. PubMed ID: 21111449
[TBL] [Abstract][Full Text] [Related]
10. EXTL3 promoter methylation down-regulates EXTL3 and heparan sulphate expression in mucinous colorectal cancers.
Karibe T; Fukui H; Sekikawa A; Shiratori K; Fujimori T
J Pathol; 2008 Sep; 216(1):32-42. PubMed ID: 18543267
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.
Nagasaka T; Sharp GB; Notohara K; Kambara T; Sasamoto H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
Clin Cancer Res; 2003 Nov; 9(14):5306-12. PubMed ID: 14614014
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
14. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of EGFL8: a novel prognostic biomarker for patients with colorectal cancer.
Wu F; Shirahata A; Sakuraba K; Kitamura Y; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2011 Jun; 31(6):2249-54. PubMed ID: 21737648
[TBL] [Abstract][Full Text] [Related]
16. Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
Shen YM; Arbman G; Sandström P; Gullstrand P; Wei YQ; Zhang H; Rosell J; Olsson B; Peng F; Yang HS; Wang CT; Sun XF
Oncol Rep; 2012 Feb; 27(2):376-82. PubMed ID: 22024937
[TBL] [Abstract][Full Text] [Related]
17. Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application.
Ogawa K; Utsunomiya T; Mimori K; Yamashita K; Okamoto M; Tanaka F; Inoue H; Ikeda Y; Saku M; Murayama S; Mori M
Int J Oncol; 2005 Aug; 27(2):417-26. PubMed ID: 16010423
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.
Li C; Cai S; Wang X; Jiang Z
PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219
[TBL] [Abstract][Full Text] [Related]
19. Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease.
Ye Q; Wang TF; Peng YF; Xie J; Feng B; Qiu MY; Li LH; Lu AG; Liu BY; Zheng MH
Oncol Rep; 2010 Feb; 23(2):429-36. PubMed ID: 20043104
[TBL] [Abstract][Full Text] [Related]
20. EPHB4 and survival of colorectal cancer patients.
Davalos V; Dopeso H; Castaño J; Wilson AJ; Vilardell F; Romero-Gimenez J; Espín E; Armengol M; Capella G; Mariadason JM; Aaltonen LA; Schwartz S; Arango D
Cancer Res; 2006 Sep; 66(18):8943-8. PubMed ID: 16982731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]